pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›Vardenafil Hydrochloride
drug · small molecule
save

vardenafil hydrochloride

Phase 2updated 3mo ago
by Respira Therapeutics Inc🔗 ChEMBL
Phase 2
community read0 votes

Small molecule drug with a maximum clinical stage of Approval (across all indications), with an approval for erectile dysfunction and impotence.

targets

cGMP-specific 3',5'-cyclic phosphodiesterase

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

brand
Vardenafil Hydrochloride
trade names
Levitra, Staxyn, Vardenafil hydrochloride, Vivanza
generic
vardenafil hydrochloride
MOA
Phosphodiesterase 5A inhibitor
indication
Pulmonary Arterial Hypertension
phase
phase_2
Data sources
ClinicalTrials.gov · OpenTargets
last refreshed 48m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?